Introduction Blood cancer diagnostics refers to the process of detecting and identifying cancers that affect the blood, bone marrow, and lympha ...

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Immune cells in thyroid adenoma and carcinoma: uncovering a hidden value of assessing tumor-host interplay and its potential application in thyroid cytopathology ...

Molecular diagnosis of HAV along with anti-HAV IgG avidity measurement are helpful in case of positive IgM where laboratory evidence of acute hepatitis is absent and there is no epidemiologic link ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, ...

Abbott Receives FDA Clearance for Self-Collected STI Molecular Test The device is intended for self-collection of samples ... Rise 4 Percent The firm reported that its full-year 2024 revenues were up ...

To bridge geographical barriers, technology-driven solutions like tele-diagnostics are gaining momentum. The integration of ...

PLEASE NOTE: The MDU has relocated to Chelsea & Westminster Hospital and is based there from 9 September 2024 onwards. The Molecular Diagnostic Unit (MDU) specialises in providing fast, accurate ...

Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...

Continued innovation and investment in molecular diagnostics will ensure broader access and better preparedness for HMPV, its variants and other respiratory illnesses.

Yuka Manabe and her team at the Center for Innovative Diagnostics for Infectious Diseases aim to improve global health with ...